Volume 17, Number 10—October 2011
Dispatch
Placental Transmission of Human Parvovirus 4 in Newborns with Hydrops, Taiwan
Table 1
Patient | Sex | Delivery | Gestational age, wk | Birthweight, g | Hydrops signs | Hemoglobin, g/dL | Transfusion† | Platelets, 103/μL | Outcome |
---|---|---|---|---|---|---|---|---|---|
A | F | CS | 35 | 2,846 | Pericardial effusion, polyhydramnios | 8.1 | Yes | NA | Survived |
B | M | Vaginal | 40 | 2,468 | Pleural effusion, skin edema | 7.9 | Yes | 183 | Survived |
C | F | CS | 32 | 3,070 | Pleural effusion, skin edema | 7.8 | Yes | 22 | Died |
D | M | CS | 35 | 3,030 | Ascites, pericardial effusion | 4.1 | Yes | 6 | Survived |
E | M | Vaginal | 27 | 1,450 | Pleural effusion, skin edema | 13 | No | 232 | Survived |
F | M | CS | 32 | 2,634 | Ascites, pleural effusion | 12 | No | 76 | Died
*CS, cesarean section; NA, not available. |
*CS, cesarean section; NA, not available.
†All transfusions were given after delivery. Blood samples were collected on the second (patients A–D) or third (E, F) day after delivery.
Page created: September 28, 2011
Page updated: September 28, 2011
Page reviewed: September 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.